Waleed Alqurashi

Investigator, CHEO Research Institute

Dr. Waleed Alqurashi completed his pediatric residency training at the Montreal Children’s Hospital and McGill University and his fellowship training in pediatric emergency medicine at the Children’s Hospital of Eastern Ontario (CHEO) and the University of Ottawa. He then completed a Master’s degree in Clinical Epidemiology at the University of Ottawa while doing a research fellowship at The Ottawa Hospital Research Institute. He also completed the Society for Academic Emergency Medicine (SAEM) research fellowship. He joined the Division of Emergency Medicine at CHEO and the Department of Emergency Medicine at the University of Ottawa in 2013. Since then, he has been a clinical investigator at the CHEO Research Institute. He secured research funding and published scholarly projects related to allergic reactions and anaphylaxis, with a particular focus on biphasic anaphylaxis, anaphylaxis epidemiology, and anaphylaxis related patient education materials.

He is a member of the CHEO Antibiotic Stewardship Program and leading a penicillin de-labelling project in the Emergency Department. Dr. Alqurashi is the Content Advisor for anaphylaxis at the Translating Emergency Knowledge for Kids (TREKK), a national centre of excellence aimed at bringing evidence-based pediatric emergency care to general emergency departments across Canada. He is also a member of the Editorial Board of the TREKK network.

Related News

Research Projects

  1. Separating Fact from Fiction in the Diagnosis and Management of Food Allergy

    19/10/2021

    The goal of this commentary is to review important themes that have emerged in our understanding of food allergy management.

  2. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-analysis, GRADE Assessment, and International Consensus Approach.

    18/06/2021

    We recommend further research to clarify SARS-CoV-2 vaccine/vaccine excipient testing utility in individuals potentially allergic to SARS-CoV2 vaccines or their excipients.

  3. The Revenge of Unintended Consequences of Anaphylaxis-Risk Overdiagnosis: How Far We Have Come and How Far We Have to Go

    17/06/2021

    medicine remains a science of uncertainty and an art of probability, a critical approach to risk mitigation remains necessary to find the often-elusive balance in anaphylaxis prevention.

  4. Skin Testing for Penicillin Allergy: a Review of the Literature

    18/03/2021

    This review provides support for risk stratification assessment of reported penicillin allergy to optimize antibiotic use and prevent emergence of antimicrobial resistance.

  5. Management of pediatric allergic reaction: Practice patterns of Canadian pediatric emergency physicians

    08/09/2020

    Most respondents recognized cases of anaphylaxis; however, a substantial number demonstrated gaps in management that may adversely impact this vulnerable population. The recognition of anaphylaxis without urticaria or pulmonary findings and treatment of anaphylaxis with epinephrine, where indicated, were the main gaps identified.